FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Acarbose Tablets
Status: Discontinuation
»Therapeutic Categories:

Expand all

Mylan Pharmaceuticals Inc. (New 12/14/2015)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Acarbose Tablets 50 mg (NDC # 0378-2821-77) 12/14/2015 Market conditions
Acarbose Tablets 25 mg (NDC # 0378-2820-77) 12/14/2015 Market conditions
Acarbose Tablets 100 mg (NDC # 0378-2822-77) 12/14/2015 Market conditions

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English